Choice and switch of biologic drugs in juvenile idiopathic arthritis
CONCLUSION: In this study, we revealed the biologic drug usage and switch strategies in our JIA patients. Good responses were obtained in most of our patients with a reliable profile. However, studies on larger patient groups are needed to clarify these results.PMID:38204313 | DOI:10.24953/turkjped.2023.22
Source: The Turkish Journal of Pediatrics - Category: Pediatrics Authors: Seher Şener Özge Başaran Ezgi Deniz Batu M üşerref Kasap Cüceoğlu Zeynep Bal ık Emil Aliyev Ya ğmur Bayındır Yelda Bilginer Seza Özen Source Type: research
More News: Arthritis | Enbrel | Humira | Pediatrics | Psoriatic Arthritis | Rheumatology | Study | Turkey Health